Maravai LifeSciences Holdings Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Maravai LifeSciences Holdings Inc.
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2834 — Pharmaceutical Preparations
Jurisdiction of incorporation: Delaware
Headquarters city: SAN Diego
Headquarters state / province: California
Headquarters country: United States
Fiscal year end: December
Ticker symbol: MRVI
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001823239
Wikidata ID: Q106239358

Board of directors

Follow this board

Anat Ashkenazi · Director
Since 2023
Benjamin James Daverman · Director
Since 2023
Bernd Brust · Director · Chief Executive Officer
Since 2025
Carl Hull · Director · See Remarks
Since 2023
Constantine S. Mihas · Director
Since 2023
Gregory T. Lucier · Director
Since 2023
Jessica Hopfield · Director
Since 2023
John A. DeFord · Director
Since 2023
Luke Joseph Marker · Director
Since 2023
Murali Prahalad · Director
Since 2023
R. Andrew Eckert · Director
Since 2024
Sean Laurence Cunningham · Director
Since 2023
Susannah Gray · Director
Since 2023

Chief executives

Bernd Brust · Chief Executive Officer

Since June 2025

0 CEO score

Weak · grade F

Out of 100, from shareholder return, dividends, growth and acquisitions.

Partial: only 20% of the scoring weight is on file.

Revenue growth 20%: 0

20% of the scoring weight is on file. Figures cover December 2024 – December 2025.

Carl Hull · Chief Executive Officer

Until June 2025 · Former

Director election results

Annual meeting of May 18, 2023. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

7 of this board's directors also sit on 11 other boards. 9 are in the same sector.

Shared director Other board Same sector

Sotera Health Company Same sector
via Constantine S. Mihas and Sean Laurence Cunningham
4D Molecular Therapeutics Inc. Same sector
via Susannah Gray
AnaptysBio Inc. Same sector
via Susannah Gray
Avantor Inc.
via Gregory T. Lucier
Becton Dickinson and Company Same sector
via R. Andrew Eckert
DENTSPLY SIRONA Inc. Same sector
via Gregory T. Lucier
Editas Medicine Inc. Same sector
via Jessica Hopfield
Fortrea Holdings Inc. Same sector
via R. Andrew Eckert
Globus Medical Inc. Same sector
via John A. DeFord
Insulet Corporation Same sector
via Jessica Hopfield
Nordson Corporation
via John A. DeFord

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $1,370,912; 4 purchases by 2 insiders
Sold, last 12 months: $254,000; 2 sales by 1 insider

Date	Insider	Transaction	Shares	Price	Value
Oct 30, 2026	Rajesh Asarpota Officer (Chief Financial Officer)	Shares withheld for tax	−5,466	$8.46	$46,242
Oct 8, 2026	Bernd Brust Director, Officer (Chief Executive Officer)	Shares withheld for tax	−29,250	$7.43	$217,328
Sep 30, 2026	Rajesh Asarpota Officer (Chief Financial Officer)	Shares withheld for tax	−5,465	$7.65	$41,807
Sep 8, 2026	Bernd Brust Director, Officer (Chief Executive Officer)	Shares withheld for tax	−29,250	$7.32	$214,110
Aug 31, 2026	Rajesh Asarpota Officer (Chief Financial Officer)	Shares withheld for tax	−5,465	$7.68	$41,971
Aug 10, 2026	Bernd Brust Director, Officer (Chief Executive Officer)	Shares withheld for tax	−29,250	$6.23	$182,228
Jul 30, 2026	Rajesh Asarpota Officer (Chief Financial Officer)	Shares withheld for tax	−5,465	$6.59	$36,014
Jul 8, 2026	Bernd Brust Director, Officer (Chief Executive Officer)	Shares withheld for tax	−29,250	$5.92	$173,160
Jun 30, 2026	Rajesh Asarpota Officer (Chief Financial Officer)	Shares withheld for tax	−65,584	$6.39	$419,082
Jun 10, 2026	ORESHACK KURT Officer (General Counsel)	Open-market sale	−25,000	$5.10	$127,500
Jun 9, 2026	ORESHACK KURT Officer (General Counsel)	Open-market sale	−25,000	$5.06	$126,500
Jun 9, 2026	Gregory T. Lucier Director	Gift	−46,293	—	—
Jun 9, 2026	Gregory T. Lucier Director	Gift	+46,293	—	—
Jun 8, 2026	Bernd Brust Director, Officer (Chief Executive Officer)	Shares withheld for tax	−351,001	$5.02	$1,762,025
May 26, 2026	Luke Joseph Marker Director	Grant or award	+46,293	—	—

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about Maravai LifeSciences Holdings Inc.

Who is the CEO of Maravai LifeSciences Holdings Inc.?

Bernd Brust has been Maravai LifeSciences Holdings Inc.'s Chief Executive Officer since June 2025.

How many directors are on Maravai LifeSciences Holdings Inc.'s board?

Maravai LifeSciences Holdings Inc.'s board has 13 directors: Anat Ashkenazi, Benjamin James Daverman, Bernd Brust, Carl Hull, Constantine S. Mihas, Gregory T. Lucier, Jessica Hopfield, John A. DeFord, Luke Joseph Marker, Murali Prahalad and 3 others.

Are Maravai LifeSciences Holdings Inc. insiders buying or selling shares?

Over the last 12 months, Maravai LifeSciences Holdings Inc. insiders bought $1.4 million of shares in 4 purchases and sold $254,000 of shares in 2 sales on the open market, as reported to the SEC on Forms 4 and 5.

How is Maravai LifeSciences Holdings Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="maravai-lifesciences-holdings-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.